Pharma Market Access Insights - from Petauri Evidence
En podkast av Petauri Evidence
64 Episoder
-
Market access in the German speaking markets
Publisert: 29.8.2023 -
The role of nursing in driving digital change in the NHS
Publisert: 26.7.2023 -
Market access for digital therapies and digital medicines
Publisert: 19.7.2023 -
A global market access journey in cannabinoid pharmaceuticals
Publisert: 17.6.2023 -
Primary Care and ICBs – what is the next step in the integration journey?
Publisert: 15.5.2023 -
Data-led transformation in the NHS - partnering to optimise patient care
Publisert: 31.3.2023 -
Innovating for better health – research, collaboration and innovation in the NHS
Publisert: 7.3.2023 -
Healthcare, economics and society – unlocking NHS collaboration
Publisert: 30.1.2023 -
Specialised Commissioning in the NHS – What do you need to know now
Publisert: 13.1.2023 -
Why are we waiting? - Pressures facing the NHS and how to deliver change
Publisert: 29.11.2022 -
Priority setting in primary care - NHS insights
Publisert: 18.10.2022 -
Integrated Care Systems go live in the NHS - reflections after 3 weeks
Publisert: 9.8.2022 -
Clinical Pharmacists – exploring the scope, capabilities, and potential of this evolving NHS role
Publisert: 1.8.2022 -
Transforming systems and care pathways for an integrated NHS
Publisert: 21.6.2022 -
Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers
Publisert: 4.5.2022 -
Population to Person: How will the NHS translate population health management into impactful, person-centred service change?
Publisert: 15.3.2022 -
Planning in a volatile environment: how will the NHS reconcile its competing priorities and operational planning to meet its challenges?
Publisert: 11.2.2022 -
The evolving NHS: How can Pharma and Medtech support the NHS in 2022? - NHS Insights Panel Discussion
Publisert: 17.1.2022 -
Optimising the NHS – How will medicines be valued in integrated systems?
Publisert: 21.12.2021 -
Rare disease market access - strategic and tactical challenges facing orphan medicines entering Europe
Publisert: 29.11.2021
We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.
